1. Shapiro-Shelef M, Calame Kathryn. Regulation of plasm-cell development. Nat Rev Immunol. 2005;5: 230-242. doi:10.1038/nri1572
2. Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM, The generation of antibody-secreting plasma cells. Nat Rev Immunol. 2015;15: 160-171. doi:10.1038/nri3795
3. Suan D, Sundling C, Brink R. Plasma cell and memory B cell differentiation from the germinal center. Current Opinion in Immunology. 2017;45: 97–102. doi:10.1016/j.coi.2017.03.006
4. Shinnakasu R, Kurosaki T. Regulation of memory B and plasma cell differentiation. Current Opinion in Immunology. 2017;45: 126–131. doi:10.1016/j.coi.2017.03.003
5. Kunkel EJ, Butcher EC. Plasma-cell homing. Nat Rev Immunol. 2003;3: 822-829. doi:10.1038/nri1203
6. Hargreaves DC, Hyman PL, Lu TT, Ngo VN, Bidgol A, Suzuki G, et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med. 2001;194: 45-56. doi:10.1084/jem.194.1.45
7. Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O. Cutting edge: profile of chemokine rexeptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J Immunol. 2003;170: 1136-1140. doi:10.4049/jimmunol.170.3.1136
8. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, MeClanahan T, et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity. 1996;4: 573-581. doi:10.1016/S1074-7613(00)70060-4
9. Tahara-Hanaoka S, Miyamoto A, Hara A, Honda S, Shibuya K, Shibuya A. Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands. Biochem Biophys Res Commun. 2005;239: 996-1000. doi:10.1016/j.bbrc.2005.02.067
10. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med. 2003;198: 557-567. doi:10.1084/jem.20030788
11. Tahara-Hanaoka S. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int Immnol. 2004;16: 533-538. doi:10.1093/intimm/dxh059
12. Aoki J, Koike S, Asou H, Ise I, Suwa H, Tanaka T, et al. Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates hemophilic cell aggregation. Exp Cell Res. 1997;235: 374-384. doi:10.1006/excr.1997.3685.
13. Maier MK, Seth S, Czeloth N, Qui Q, Ravens I, Kremmer E, et al. The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens. Eur J Immunol. 2007;37: 2214-2225. doi:10.1002/eji.200737072
14. Lopez M, Aoubala M, Jordier F, Isnardon D, Gomez S, Dubreuil P. The human poliovirus receptor related 2 protein is a new hematopoietic/endothelial hemophilic adhesion molecule. Blood. 1998;92: 4602-4611. http://www.bloodjournal.org/content/92/12/4602
15. Tahara-Hanaoka S, Shibuya K., Kai H, Miyamoto A, Morikawa Y, Ohkochi N, et al. Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. Blood. 2006;107: 1491-1496. doi:10.1182/blood-2005-04-1684.
16. EI-Sherbiny YM, Meade JL, Holmes TD, McGonagle D, Mackie SL, Morgan AW, et al. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res. 2007;67: 8444-8449. doi:10.1158/0008-5472.CAN-06-4230
17. Verhoeven DH, de Hooge AS, Mooiman EC, Santos SJ, tem Dam MM Gelderblom H, et al. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Mol Immunol. 2008; 45: 3917-3925. doi:10.1016/j.molimm.2008.06.016
18. Ravens I, Seth S, Forster R, Bernhardt G. Characterization and identification of Tage4 as the murine orthologue of human poliovirus receptor/CD155. Biochem Biophys Res Commun. 2003;312: 1364-1371. doi:10.1016/j.bbrc.2003.11.067
19. Chadeneau C, LeCabellec M, LeMoullac B, Meflah K, Denis, MG. Overexpression of a novel member of the immunoglobulin superfamily in Min mouse intestinal adenomas. Int J Cancer. 1996;68: 817-821, doi:10.1002/(SICI)1097-0215(19961211)68:63.0.CO;2- W
20. Morrison ME, Racaniello VR. Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene. J Virol. 1992; 66: 2807-2813. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC241037/
21. Iguchi-Manaka A, Kai H, Yamashita Y, Shibata K, Tahara-Hanaoka S, Honda S, et al. Accelerated tumor growth in mice deficient in DNAM-1 receptor. J Exp Med. 2008;205: 2959-2964. doi:10.1084/jem.20081611.
22. Shibuya K, Shirakawa J, Kameyama T, Honda S, Tahara-Hanaoka S, Miyamoto A, et al. CD226 (DNAM-1) is involved in lymphocyte functionassociated antigen 1 costimulatory signal for naïve T cell differentiation and proliferation. J Exp Med. 2003;198: 1829-1839. doi:10.1084/jem.20030958
23. Grossman L, Chand C, Dai J, Nikitin PA, Jima DD, Dave SS, et al. Epstein-barr virus indices adhesion receptor CD226 (DNAM-1) expression during primar B cell transformation into lymphoblastoid cell lines. mSphere. 2017;2: 1-11. doi:10.1128/mSphere.00305-17
24. Berglund LJ, Avery DT, Ma CS, Moens L, Deenick EK, Bustamante J, et al. IL-21 signaling via STAT3 primes human naïve B cells to respond to IL-2 to enhanve their differentiation into plasmablasts. Blood. 2013;122: 3940-50. doi:10.1182/blood-2013-06-506865
25. Du Y, Tian L, Shen LX, Wang F, Yu LK, Song Y et al. Association of the CD226 single nucleotide polymorphism with systemic lupus eruthematosus in the Chinese Han Population. Tissue Antigen. 2011;77: 65-67. doi:10.1111/j.1399-0039.2010.01568.x
26. Ayano M, Tsukamoto H, Kohno K, Ueda N, Tanaka A, Mitoma H, et al. Increased CD226 expression on CD8+ T cells is associated with upregulated cytokine production and endothelial cell injury in patients with systemic sclerosis. J Imunol. 2015;195: 892-900. doi:10. 4049/jimmunol.1403046.
27. Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, Irving B, et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol. 2009;10: 48-57. doi:10.1038/ni.1674.
28. Fuchs A, Cella M, Giurisato E, Shaw AS, Colonna M. Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J Immunol. 2004;172: 3994-3998. doi:10.4049/jimmunol.172.7.3994
29. Stanietsky N, Simic H, Arapovic J, Toporik A, Levy O, Novik A, et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc Natl Acad Sci. 2009;106: 17853-17863. doi:10.1073/pnas.0903474106
30. Wang PL, O’Farrell C, Clayberger C, Krensky AM. Identification and molecular cloning of tactile. A novel human T cell activation antigen that is a member of the Ig gene superfamily. J Immunol. 1992;148: 2600-2608. http://www.jimmunol.org/content/148/8/2600
31. Chan CJ, Martinet L, Gilfillan S, Souza-Fonseca-Guimaraes F, Chow MT, Town L, et al. The receptor CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat Immunol. 2014;15: 431-438. doi:10.1038/ni.2850
32. Palumbo A, Anderson K. Multiple myeloma. N Eng J Med. 2011;364: 1046-1060. doi:10.1056/NEJMra1011442
33. Robak P, Drozdz I, Szemraj J, Robak T. Drug resistance in multiple myeloma. Cancer Treat Rev. 2018;70: 199-208. doi:10.1016/j.ctrv.2018.09.001.
34. Guillerey C, Ferrari de Andrade L, Vuckovic S, Miles K, Ngiow SF, Yong MC, et al. Immunosurveillance and therapy of multiple myeloma are CD226 dependent. J Clin Invest. 2015;125: 2904. doi:10.1172/JCI82646
35. Flonda C, Soriani A, Zingoni A, Santoni A, Cippitelli M. NKG2D and DNAM-1 ligands: molecular targets for NK cell-mediated immunotherapeutic intervention in multiple myeloma. Biomed Res Int. 2015;2015: 178698. doi:10.1155/2015/178698
36. El-Sherbiny YM, Meade JL, Holmes TD, McGonagle D, Mackie SL, Morgan AW, et al. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res. 2007;67: 8444-8449. doi:10.1158/0008-5472.CAN-06-4230
37. Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 2005;436: 1186-1190. doi:10.1038/nature03884
38. Soriani A, Zingoni A, Cerboni C, Iannitto ML, Roccoardo MR, Di Gialleonardo V, et al. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enganced NK-cell susceptibility and is associated with a senescent phenotype. Blood. 2009;113:3503-3511. doi:10.1182/blood2008-08-173914.
39. Sonmez O, Sonmez M. Role of platelets in immune system and inflammation. Port Biomed J. 2017;2: 311-314. doi:10.1016/j.pbj.2017.05.005
40. Lam FW, Vijavan KV, Rumbaut RE. Platelets and their interactions with other immune cells. Compr Physiol. 2015;5: 1265-1280. doi:10.1002/cphy.cl40074
41. Li N, Ji Q, Hjemdahl P. Platelet-lymphocyte conjugation differs between lymphocyte subpopulations. J Thromb Haemost. 2006;4: 874-881. doi:10.1111/j.1538-7836.2006.01817.x
42. Cognasse, F., Hamzeh-Cognasse, H., Lafarge, S., Chavarin, P., Cogne, M., Richard, Y., Garraud, O., 2007. Human platelets can activate peripheral blood B cells and increase production of immunoglobulins. Exp Hematol. 35, 1376-1387, doi:10.1016/j.exphem.2007.05.021
43. Kojima H, Kanada H, Shimizu S, Kasama E, Shibuya K, Nakauchi H, et al. CD226 mediate platelet and megakaryocytic cell adhesion to vascular endothelial cells. J Biol Chem. 2003;278: 36748-36753. doi:10.1074/jbc.M300702200
44. Maecker HT, McCoy JP, Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat Rev Immunol. 2012;12: 191-200. doi:10.1038/nri3158
45. Avery DT, Ellyard JI, Mackay F, Corcoran LM, Hodgkin PD, Tangye SG. Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage. J Immunol. 2005;174: 4034-4042. doi:10.4049/jimmunol.174.4.4034
46. Rawstron AC. Immunophenotyping of plasma cells. Curr Protoc Cytom. 2006;36: 6.23.1-6.23.14. doi:10.1002/0471142956.cy0623s36.
47. Barwick BG, Scharer CD, Bally APR, Boss JM. Plasma cell differentiation is coupled to division-dependent DNA hypomethylation and gene regulation. Nat Immunol. 2016;17: 1216-1225. doi:10.1038/ni.3519
48. Kim D, Park CY, Medeiros BC, Weissman IL. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells. Leukemia. 2012;26: 2530-2537. doi:10.1038/leu.2012.140
49. Nakano-Yokomizo T, Tahara-Hanaoka S, Nakanishi-Oda C, Nabekura T, Tchao NK, Kadosaki M, et al. The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses. J Exp Med. 2011;208: 1661-1671. doi:10.1084/jem.20101623
50. Van Belle K, Herman J, Boon L, Waer M, Sprangers B, Louat T. Comparative in vitro immune stimulation analysis of primary human B cells and B cell lines. J Immunol Res. 2016:2016: 5281823. doi:10.1155/2016/5281823.
51. Niehage C, Steenblock C, Pursche T, Bornhauser M, Corbeil D, Hoflack B. The cell surface proteome of human mesenchymal stromal cells. PLoS One. 2011;6: e20399. doi: 10.1371/journal.pone.0020399
52. Pak HK, Gil M, Lee Y, Lee H, Lee AN, Roh J, Park CS. Regulator of G protein signaling 1 suppresses CXCL12-mediated migration and AKT activation in RPMI 8226 human plasmacytoma cells and plasmablasts. PLoS One. 2015;10: e0124793. doi:10.1371/journal.pone.0124793
53. D Payne, S Drinkwater, R Baretto, M Duddridge, MJ Browning. Expression of chemokine receptors CXCR4, CXCR5 and CCR7 on B and T lymphocytes from patients with primary antibody deficiency. Clin Exp Immunol. 2009;156: 254-262. doi:10.1111/j.1365-2249.2009.03889.x
54. Daien Cl, Gailhac S, Mura T, Audo R, Combe B, Hahne M, et al. Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity. Arthritis Rheumatol. 2014;66: 2037-2046. doi:10.1002/art.38666.
55. Shen P, Roch T, Lampropoulou V, O’Connor RA, Stervbo U, Hilgenberg E, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014;507: 366-370. Doi:10.1038/nature12979
56. Matsumoto M, Baba A, Yokota T, Nishikawa H, Ohkawa Y, Kayama H, et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity. 2014;41: 1040-1051. doi:10.1016/j.immuni.2014.10.016
57. Bemasconi NL, Traggiai E, Lanzavecchia A., Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 2002;298: 2199-2202. doi:10.1126/science.1076071
58. Joo H, Coquery C, Xue Y, Gayet I, Dillion SR, Punaro M, et al. Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation. J Exp Med. 2012;209: 1335-1348. doi:10.1084/jem.20111644
59. Heine G, Drozdenko G, Grun JR, Change HD, Radbruch A, Worm M. Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgGsecreting plasmablasts. Eur J Immunol. 2014;44: 1615-1621. doi:10.1002/eji.201343822
60. Malisan F, Briere F, Bridon JM, Harindranath N, Mills FC, Max EE, et al. Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naïve B lymphocytes. J Exp Med. 1996;183: 937-947. doi:10.1084/jem.183.3.937
61. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleuklin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19: 683-765. doi:10.1146/annurev.immunol.19.1.683
62. Ping S, Toralf R, Vicky L, Richard AO, Ulrik S, Ellen H, et al. IL-35- producing C cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014;507: 366-370. doi:10.1038/nature 12979
63. Takagi A, Tsukamoto S, Kawano Y, Moschetta M, Mishima Y, Kokubun K, et al. Platelets/Megakaryocytes are critical regulators of tumor progression in multiple myeloma. Blood. 2015;126: 1793